ClinicalTrials.Veeva

Menu

A Retrospective Assessment of OviTex PRS (OviTex)

T

Tela Bio

Status

Enrolling

Conditions

Reconstructive Surgical Procedures

Treatments

Device: OviTex® PRS

Study type

Observational

Funder types

Industry

Identifiers

NCT05736848
TB2022.01.02

Details and patient eligibility

About

The objective of this retrospective-prospective, observational study is to evaluate the safety profile overall and within two device types of OviTex PRS in previous pre-pectoral or sub-pectoral implant-based breast reconstructions.

Full description

This study is organized as a retrospective-prospective, observational, multi-center study. The treatment group involved in the study received OviTex PRS during implant-based breast reconstruction. The reconstruction procedure was an immediate or two-stage unilateral or bilateral implant in either the sub-pectoral or pre-pectoral position. Results from this study are aimed to demonstrate an acceptable safety profile and to inform the study design and effectiveness endpoints of a future prospective study.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient was between 18 years and 75 years of age (inclusive) at the time of surgery.
  2. At the time of surgery, the patient received an OviTex PRS Permanent (R20143 or R20243) or Resorbable (R20152 or R20252) implant in conjunction with an implant-based breast reconstruction.
  3. Patient has undergone their initial surgical procedure and exchange surgery (if applicable).

Exclusion criteria

  1. Patient received a textured permanent breast implant.
  2. Patient was a nicotine user (including smokeless, vaporized, etc.) within 4-weeks preceeding their index procedure.
  3. Patient had previously undergone radiation therapy to the chest wall prior to index surgery.

Additional prospective inclusion criteria (if applicable):

  1. Patient agrees to return in-person for prospective portion including the completion of photographs.

Additional prospective exclusion criteria (if applicable):

  1. Patient has a history of a psychological condision, drug or alcohol abuse which may interfere with their ability to adhere to the follow-up requirements.

Trial contacts and locations

11

Loading...

Central trial contact

Zachary Sterner; Danielle Campbell

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems